Hackensack Meridian Health Oncology
Machine Learning Helps ID Patients Who May Not Respond to Certain Diffuse Large B-Cell lymphoma Treatments in Hackensack University Medical Center Study
Transcriptome Analysis Gives Insight on Post-Treatment Survival Characteristics to Show Who May Not Respond Well to Traditional Drug Approaches
CANDOR Study Gives Hope for Relapsed and Refractory Myeloma at Hackensack University Medical Center
Phase III Trial Confirms Carfilzomib and Dexamethasone as Emerging Standard of Care
Hackensack University Medical Center Investigates Safety and Efficacy of Promising Precision Therapy in FIGHT-101 Trial
Marks First In-Human Study of FGFR 1-3 Inhibitor Pemigatinib
Today’s Most Important Oncology Papers Identified by Hackensack University Medical Center Leader
John Theurer Cancer Center Chairman Andre Goy Selects Field’s Top Four Publications Shifting the Direction of Cancer Care
GPS-Style Ion Lung Cancer Tool Now at Hackensack University Medical Center
Guidance Technology Brings Precision and Efficiency to Nodule Detection and Removal
ZUMA-7 Study Shows Value of CAR T-Cell Therapy as Second-Line Treatment for Relapsed Large B-Cell Lymphoma
John Theurer Cancer Center Investigators Participate in Study Set to Shift 40-Year Standard of Care
Ponatinib Dose-Ranging Study Pinpoints Optimal Dose for Treating Chronic Myeloid Leukemia
Phase 2 Trial Identifies Dosage Strategy to Maximize Efficacy and Reduce Risk of Arterial Occlusions
First CAR T Therapy to Treat Multiple Myeloma Offers Hope to Patients No Longer Responsive to Standard Therapy
FDA Approves Abecma Following Phase II KarMMA Trial at Hackensack Meridian John Theurer Cancer Center
Brexu-cel Clinical Practice Safety Report by Lymphoma CAR T Consortium
Hackensack University Medical Center Among Centers Reporting Positive Results at American Society of Hematology Meeting
Hackensack University Medical Center Surgeon Offers Tips for Patient Compliance with New Colorectal Cancer Screening Age
Screening Options and Common Questions to Anticipate with New Screening Start Age of 45
Hackensack Meridian Health Genomic Profiling Lab Advances Blood Cancer and Solid Tumor Care
Partnership with Genomic Testing Cooperative Helps Oncologists Precisely Diagnose Cancer and Develop Treatment Plans
Promising Immunotherapy Explored in CAR T-Cell Trials at John Theurer Cancer Center at Hackensack University Medical Center
Successful Remission Achieved for Recurring Multiple Myeloma Patient Participating in CAR T-Cell Trial
Lymphoma in Remission Thanks to New Form of Immunotherapy at Hackensack University Medical Center
Mantle Cell Lymphoma Patient Case Study Demonstrates Powerful Impact of CAR T-Cell Therapy
Cancer Research Breakthroughs at Hackensack University Medical Center
Roundup of the Most Promising Clinical and Lab Discoveries Fueled by the Center for Discovery & Innovation
Hackensack University Medical Center Breast Surgeons Demonstrate New Technology for Marking Location of Cancerous Lymph Nodes
Tool Shown Accurate and Effective in Making Procedure More Comfortable for Patients